Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marine Andreani

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|March 7, 2019
[Glomerular nephropathy]Marine Andreani, Vincent Esnault
La Revue Du Praticien|March 7, 2019
[Glomerular diseases in brief]Marine Andreani, Vincent Esnault
Heliyon|December 30, 2024
Whole-genome sequencing revealed a novel structural variant in <i>COL4A4</i> causing autosomal dominant Alport syndrome: A case reportClément Delage, Marine Andreani, Nihad Boukrout, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2019
Rituximab bioavailability in primary membranous nephropathySonia Boyer-Suavet, Marine Andreani, Marion Cremoni, et al.
Transplantation Proceedings|January 1, 2020
Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D+/R-): A Case SeriesMarine Andreani, Laetitia Albano, Sylvia Benzaken, et al.
Frontiers in Immunology|January 31, 2020
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With RituximabSonia Boyer-Suavet, Marine Andreani, Maël Lateb, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 15, 2022
Onco-nephrology: Physicians' Expectations About a New SubspecialtyMatthieu Delaye, Mélanie Try, Adrien Rousseau, et al.
Kidney International Reports|July 11, 2022
Drug-Induced Tubulointerstitial Nephritis: Insights From the World Health Organization Safety DatabaseAlexandre O Gérard, Diane Merino, Audrey Laurain, et al.
Frontiers in Immunology|December 16, 2020
Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and RelapsesMarion Cremoni, Vesna Brglez, Sandra Perez, et al.
Frontiers in Immunology|February 6, 2025
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance databaseAlexandre O Gérard, Diane Merino, Jonathan Benzaquen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|March 7, 2019
[Glomerular nephropathy]Marine Andreani, Vincent Esnault
La Revue Du Praticien|March 7, 2019
[Glomerular diseases in brief]Marine Andreani, Vincent Esnault
Heliyon|December 30, 2024
Whole-genome sequencing revealed a novel structural variant in <i>COL4A4</i> causing autosomal dominant Alport syndrome: A case reportClément Delage, Marine Andreani, Nihad Boukrout, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2019
Rituximab bioavailability in primary membranous nephropathySonia Boyer-Suavet, Marine Andreani, Marion Cremoni, et al.
Transplantation Proceedings|January 1, 2020
Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D+/R-): A Case SeriesMarine Andreani, Laetitia Albano, Sylvia Benzaken, et al.
Frontiers in Immunology|January 31, 2020
Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With RituximabSonia Boyer-Suavet, Marine Andreani, Maël Lateb, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 15, 2022
Onco-nephrology: Physicians' Expectations About a New SubspecialtyMatthieu Delaye, Mélanie Try, Adrien Rousseau, et al.
Kidney International Reports|July 11, 2022
Drug-Induced Tubulointerstitial Nephritis: Insights From the World Health Organization Safety DatabaseAlexandre O Gérard, Diane Merino, Audrey Laurain, et al.
Frontiers in Immunology|December 16, 2020
Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and RelapsesMarion Cremoni, Vesna Brglez, Sandra Perez, et al.
Frontiers in Immunology|February 6, 2025
PDL1 inhibitors may be associated with a lower risk of allograft rejection than PD1 and CTLA4 inhibitors: analysis of the WHO pharmacovigilance databaseAlexandre O Gérard, Diane Merino, Jonathan Benzaquen, et al.
Pageof 2